177 related articles for article (PubMed ID: 28151704)
21. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
22. Sleep duration, melatonin and breast cancer among Chinese women in Singapore.
Wu AH; Wang R; Koh WP; Stanczyk FZ; Lee HP; Yu MC
Carcinogenesis; 2008 Jun; 29(6):1244-8. PubMed ID: 18448486
[TBL] [Abstract][Full Text] [Related]
23. Association between 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and risk of postmenopausal breast cancer: nested case-control study.
Loft S; Olsen A; Møller P; Poulsen HE; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1289-96. PubMed ID: 23658396
[TBL] [Abstract][Full Text] [Related]
24. Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis.
Xu J; Huang L; Sun GP
Sci Rep; 2017 Jul; 7(1):5353. PubMed ID: 28706222
[TBL] [Abstract][Full Text] [Related]
25. Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer.
Barba M; Cavalleri A; Schünemann HJ; Krogh V; Evangelista A; Secreto G; Micheli A; Zhou Q; Fuhrman B; Teter B; Berrino F; Muti P
Int J Biol Markers; 2006; 21(4):242-5. PubMed ID: 17177163
[TBL] [Abstract][Full Text] [Related]
26. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
28. The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers.
Ramin CA; Massa J; Wegrzyn LR; Brown SB; Pierre-Paul J; Devore EE; Hankinson SE; Schernhammer ES
BMC Public Health; 2015 May; 15():467. PubMed ID: 25943349
[TBL] [Abstract][Full Text] [Related]
29. Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.
Goodman MT; Shvetsov YB; Wilkens LR; Franke AA; Le Marchand L; Kakazu KK; Nomura AM; Henderson BE; Kolonel LN
Cancer Prev Res (Phila); 2009 Oct; 2(10):887-94. PubMed ID: 19789300
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of urinary melatonin in women and its relation to other hormones and night work.
Schernhammer ES; Rosner B; Willett WC; Laden F; Colditz GA; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):936-43. PubMed ID: 15184249
[TBL] [Abstract][Full Text] [Related]
31. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women.
Travis RC; Allen NE; Peeters PH; van Noord PA; Key TJ
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):806-8. PubMed ID: 12917214
[TBL] [Abstract][Full Text] [Related]
32. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
Moore SC; Matthews CE; Ou Shu X; Yu K; Gail MH; Xu X; Ji BT; Chow WH; Cai Q; Li H; Yang G; Ruggieri D; Boyd-Morin J; Rothman N; Hoover RN; Gao YT; Zheng W; Ziegler RG
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27193440
[TBL] [Abstract][Full Text] [Related]
33. Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study.
Reeves KW; Okereke OI; Qian J; Tamimi RM; Eliassen AH; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):306-314. PubMed ID: 29263188
[No Abstract] [Full Text] [Related]
34. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
Schernhammer ES; Kroenke CH; Dowsett M; Folkerd E; Hankinson SE
J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548
[TBL] [Abstract][Full Text] [Related]
35. Systemic Levels of Estrogens and PGE
Kim S; Campbell J; Yoo W; Taylor JA; Sandler DP
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):383-388. PubMed ID: 27864342
[No Abstract] [Full Text] [Related]
36. A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
McMullan CJ; Rimm EB; Schernhammer ES; Forman JP
Heart; 2017 May; 103(9):694-701. PubMed ID: 27806988
[TBL] [Abstract][Full Text] [Related]
37. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
38. Urine 6-sulfatoxymelatonin levels are inversely associated with arterial stiffness in post-menopausal women.
Lee JY; Lee DC
Maturitas; 2014 Jun; 78(2):117-22. PubMed ID: 24780409
[TBL] [Abstract][Full Text] [Related]
39. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
